ANI Pharmaceuticals | ANIP - Assets


ANI Pharmaceuticals reported $1.41B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
ANI Pharmaceuticals USD 1.41B 65.15M Sep/2025
Assertio Holdings USD 319.77M 46M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Heron Therapeutics USD 248.95M 16.86M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Omeros USD 200.57M 34.59M Jun/2025
Perrigo USD 10.08B 10.1M Sep/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025